179 related articles for article (PubMed ID: 37698235)
21. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
[TBL] [Abstract][Full Text] [Related]
22. Urine and serum interleukin 35 as potential biomarkers of lupus nephritis.
Nassif MA
Cent Eur J Immunol; 2021; 46(3):351-359. PubMed ID: 34764807
[TBL] [Abstract][Full Text] [Related]
23. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
24. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
Qi L; Xu J; Yang C; Hou X; Yang P
Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
[TBL] [Abstract][Full Text] [Related]
25. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.
Ding H; Shen Y; Lin C; Qin L; He S; Dai M; Okitsu SL; DeMartino JA; Guo Q; Shen N
Arthritis Res Ther; 2022 Mar; 24(1):77. PubMed ID: 35346341
[TBL] [Abstract][Full Text] [Related]
26. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
27. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
[TBL] [Abstract][Full Text] [Related]
28. Serum beta-2 microglobulin as a predictor of nephritis, disease activity, and damage score in systemic lupus erythematosus: a cross-sectional study.
Gamal DM; Badr FM; Taha SIAEF; Moustafa NM; Teama MAEM
Rheumatol Int; 2023 Feb; 43(2):323-333. PubMed ID: 36205758
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
30. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
31. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
Front Immunol; 2020; 11():671. PubMed ID: 32351512
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
33. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family.
Shater H; Fawzy M; Farid A; El-Amir A; Fouad S; Madbouly N
Lupus; 2022 Jan; 31(1):55-64. PubMed ID: 34978958
[TBL] [Abstract][Full Text] [Related]
34. Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus.
Aljaberi N; Wenderfer SE; Mathur A; Qiu T; Jose S; Merritt A; Rose J; Devarajan P; Huang B; Brunner H
Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35568436
[TBL] [Abstract][Full Text] [Related]
35. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
[TBL] [Abstract][Full Text] [Related]
36. Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis.
Abediazar S; Jafari-Nakhjavani M; Ghorbanihaghjo A; Shekarchi M; Zununi Vahed S
Iran J Kidney Dis; 2019 Nov; 13(6):389-397. PubMed ID: 31880585
[TBL] [Abstract][Full Text] [Related]
37. Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium.
Soliman SA; Haque A; Mason S; Greenbaum LA; Hicks MJ; Mohan C; Wenderfer SE
Lupus; 2021 Aug; 30(9):1394-1404. PubMed ID: 33990158
[TBL] [Abstract][Full Text] [Related]
38. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
[TBL] [Abstract][Full Text] [Related]
39. [Risk factors of childhood systemic lupus erythematosus with thyroid dysfunction].
Zhang YY; Huang LM; Cao L; Zhi YZ; Zhang JJ
Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):250-255. PubMed ID: 36849353
[No Abstract] [Full Text] [Related]
40. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
